With Danaher (DHR) having recently lost out to private equity firms on buyout targets it was seeking, analysts at Janney Montgomery Scott speculated that the conglomerate could set its sights on targets such as PerkinElmer (PKI), Agilent's (A) life sciences unit, or an international target like Oxford Instruments of the U.K., said Bloomberg's "Real M&A" column. Citigroup analysts suggest Danaher could also consider a breakup instead of an acquisition, the report noted.
- Mergers, Acquisitions & Takeovers
- private equity firms
- Janney Montgomery Scott